Insider Selling: Option Care Health, Inc. (NASDAQ:OPCH) Insider Sells 30,996 Shares of Stock

Option Care Health, Inc. (NASDAQ:OPCHGet Free Report) insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Option Care Health Stock Up 0.5 %

OPCH opened at $34.12 on Wednesday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.57. The stock has a market capitalization of $5.81 billion, a P/E ratio of 28.67, a P/E/G ratio of 2.30 and a beta of 1.35. The business has a 50 day simple moving average of $29.15 and a 200-day simple moving average of $28.09.

Institutional Investors Weigh In On Option Care Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Raymond James & Associates grew its stake in shares of Option Care Health by 6.3% during the 3rd quarter. Raymond James & Associates now owns 85,279 shares of the company’s stock worth $2,669,000 after purchasing an additional 5,049 shares during the period. International Assets Investment Management LLC boosted its holdings in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after buying an additional 2,757 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in Option Care Health during the third quarter worth about $206,000. State of Alaska Department of Revenue grew its position in Option Care Health by 3.8% during the third quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company’s stock worth $621,000 after buying an additional 735 shares during the period. Finally, Nisa Investment Advisors LLC increased its holdings in Option Care Health by 7.0% in the third quarter. Nisa Investment Advisors LLC now owns 14,526 shares of the company’s stock valued at $455,000 after buying an additional 945 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

OPCH has been the subject of a number of research reports. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. UBS Group began coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Barrington Research boosted their target price on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average target price of $32.88.

Check Out Our Latest Analysis on OPCH

Option Care Health Company Profile

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

See Also

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.